DOSSIER · 13F Holders · Q2 2026
SIGY
Sigyn Therapeutics Inc
1 institutions still hold Sigyn Therapeutics Inc as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 82674U205·1 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
1 institutions reported SIGY in Q2 2026. Howard Capital Management Group, LLC leads at 100.0% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.